|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08-19 | Moderna, Merck breakthrough could usher in wave of cancer vaccines | RE |
| Market Cap | 160B 137B 128B 117B 220B 15,308B 223B 1,515B 591B 7,690B 601B 588B 25,435B | P/E 2026 * |
17.6x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 207B 178B 166B 152B 286B 19,851B 289B 1,965B 766B 9,972B 779B 762B 32,983B | EV / Sales 2026 * |
3.33x | EV / Sales 2027 * | 3.39x |
| Free-Float |
59.05% | Yield 2026 * |
6.13% | Yield 2027 * | 6.18% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | ||
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | ||
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | ||
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | ||
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | ||
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | ||
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | ||
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | ||
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | ||
| Average | +1.29% | +4.97% | +31.31% | +53.20% | 422.21B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.31% | +72.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 53.31B 49.88B 45.66B 85.7B 5,955B 86.83B 589B 230B 2,991B 234B 229B 9,894B | 59.84B 51.26B 47.96B 43.9B 82.39B 5,725B 83.48B 567B 221B 2,876B 225B 220B 9,513B |
| Net income | 8.9B 7.62B 7.13B 6.53B 12.26B 852B 12.42B 84.28B 32.87B 428B 33.42B 32.69B 1,415B | 11.08B 9.49B 8.88B 8.13B 15.26B 1,060B 15.46B 105B 40.92B 533B 41.61B 40.7B 1,761B |
| Net Debt | 47.48B 40.67B 38.06B 34.84B 65.38B 4,543B 66.24B 450B 175B 2,282B 178B 174B 7,549B | 42.88B 36.73B 34.37B 31.46B 59.05B 4,103B 59.83B 406B 158B 2,061B 161B 158B 6,817B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions


















